Cargando…
Prognostic value of serum CYFRA21-1 and CEA for non-small-cell lung cancer
The aim of the study was to assess the clinical prognostic value of serum cytokeratin 19 fragment (CYFRA21-1) and carcinoembryonic antigen (CEA) for non-small-cell lung cancer (NSCLC) patients. Literatures related to effects of serum CYFRA21-1 and CEA on the prognosis of lung cancer patients were re...
Autores principales: | Zhang, Zhi-Hui, Han, Yun-Wei, Liang, Hui, Wang, Le-Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4673989/ https://www.ncbi.nlm.nih.gov/pubmed/26333429 http://dx.doi.org/10.1002/cam4.493 |
Ejemplares similares
-
Postoperative CYFRA 21-1 and CEA as prognostic factors in patients with stage I pulmonary adenocarcinoma
por: He, Ying, et al.
Publicado: (2017) -
Diagnostic Value of FTO Combined with CEA or CYFRA21-1 in Nonsmall Cell Lung Cancer
por: Shang, Liqun, et al.
Publicado: (2021) -
Diagnostic value of CA‐153 and CYFRA 21‐1 in predicting intraocular metastasis in patients with metastatic lung cancer
por: Lin, Qi, et al.
Publicado: (2019) -
Retracted: Diagnostic Value of FTO Combined with CEA or CYFRA21-1 in Nonsmall Cell Lung Cancer
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023) -
The value of combined detection of CEA, CYFRA21-1, SCC-Ag, and pro-GRP in the differential diagnosis of lung cancer
por: Li, Jiezhou, et al.
Publicado: (2021)